Skip to content

Clinical trials

Phase 2 Disease Progression trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disease Progression Phase: Phase 2 Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20051
20064
20072
20083
20092
20112
20123
20132
20151
20161
20173
20182
20192
20202
20215
20232
20242
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status10
Terminated8
Not yet recruiting6
Recruiting5
Withdrawn2
Suspended1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
AGC Biologics S.p.A.2
Assistance Publique - Hôpitaux de Paris2
Weill Medical College of Cornell University2
AC Camargo Cancer Center1
ARCAGY/ GINECO GROUP1
Agouron Pharmaceuticals1
Ain Shams University1
Azienda Ospedaliero-Universitaria di Modena1
Centre Leon Berard1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disease Progression49
Glioma4
HIV Infections4
Recurrence4
Brain Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Glioblastoma3
Neoplasm Metastasis3
Ovarian Neoplasms3
Prostatic Neoplasms3

Trials

Showing 26 to 49 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.